|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 |
| (11) | Patento numeris | 3250604 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16703448.7 |
| Europos patento paraiškos padavimo data | 2016-01-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-12-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/051467 |
| Data | 2016-01-25 |
| (87) | Numeris | WO 2016/120216 |
| Data | 2016-08-04 |
| (30) | Numeris | Data | Šalis |
| 201570044 | 2015-01-26 | DK |
| (72) |
SASU, Barbra Johnson, US
RAJPAL, Arvind, US
DUCHATEAU, Philippe, FR
JUILLERAT, Alexandre, US
VALTON, Julien, FR
|
| (73) |
Cellectis,
8, rue de la Croix Jarry, 75013 Paris,
FR
Allogene Therapeutics, Inc., 210 E. Grand Avenue, South San Francisco, CA 94080, US |
| (54) | MAB-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS |
| MAB-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS |